Advancements in Emerging Molecular Approaches: Promising Diagnostic and Therapies Methods for Triple-Negative Breast Cancer (TNBC) Treatment

Background and Aim: This review explores recent advancements in molecular and cellular approaches for therapeutic interventions and diagnostic methods in Triple-Negative Breast Cancer (TNBC). It aims to investigate novel therapies targeting specific molecular pathways to transform TNBC treatment and improve patient outcomes.
Method: The methodology involves a systematic analysis of recent research findings, clinical trials, and developments related to molecular and cellular approaches in TNBC. A comprehensive literature review was conducted, encompassing relevant articles, studies, and clinical trial reports. The selected data were critically evaluated to extract valuable insights into emerging therapeutic interventions and diagnostic modalities for TNBC.
Results: The review consolidates findings from recent research and clinical trials, presenting a comprehensive overview of the current landscape of molecular and cellular approaches in TNBC. It synthesizes information on novel therapies targeting specific molecular pathways, highlighting their potential efficacy and impact on patient outcomes. Additionally, the review discusses the role of molecular techniques in early and accurate TNBC diagnosis, emphasizing the strides made toward personalized and targeted treatment options.
Conclusion: In conclusion, this review underscores the significant promise held by cutting-edge molecular and cellular approaches in shaping the future of TNBC management. The insights suggest a transformative potential for novel therapies, offering hope for improved treatment strategies and outcomes in TNBC patients. Furthermore, the integration of molecular techniques in the diagnostic landscape presents an exciting avenue for advancing personalized and targeted approaches, heralding a new era in the fight against TNBC.